On August 16, 2012, the U.S. Court of Appeals for the Federal Circuit handed down its opinion in the case of Ass’n for Molecular Pathology v. U.S. Patent & Trademark Office (No. 2010-1406) (see PDF here). At issue in this case was whether Myriad Genetics, Inc.’s claims for certain compositions of matter (isolated DNA molecules)…Read More
Federal Circuit Addresses Patent Eligibility of Myriad Genetics Claims
Posted on August 26, 2012 in Health Information Technology
Published by: Hall Render